A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer

Immune checkpoint inhibitors (ICIs) therapy has been successfully utilized in the treatment of multiple tumors, but only a fraction of patients with gastric cancer (GC) could greatly benefit from it. A recent study has shown that the tumor microenvironment (TME) can greatly affect the effect of immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiang, Zhang, Lipeng, Qian, Yan, Fang, Qian, Xiao, Yongbiao, Chen, Guizeng, Cai, Guojing, Abula, Alimujiang, Wang, Zhao, Zhai, Ertao, Chen, Jianhui, Cai, Shirong, Wu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692477/
https://www.ncbi.nlm.nih.gov/pubmed/36422531
http://dx.doi.org/10.3390/ph15111401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692477/
https://www.ncbi.nlm.nih.gov/pubmed/36422531
http://dx.doi.org/10.3390/ph15111401

Ejemplares similares